Proteinases and their receptors in inflammatory arthritis: an overview

Rheumatoid Arthritis

Modulation of inflammatory arthritis by gut microbiota through mucosal inflammation and autoantibody generation

Arthritis Rheumatol.

Jubair WK, Hendrickson JD, Severs EL, Schulz HM, Adhikari S, Ir D, Pagan J, Anthony R, Robertson CE, Frank DN, Banda NK, Kuhn KA.

doi: 10.1002/art.40490.

Rheumatoid Arthritis

Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis

Arthritis Res Ther.

Yoo J, Lee SK, Lim M, Sheen D, Choi EH, Kim SA

doi: 10.1186/s13075-017-1334-9.

Rheumatoid Arthritis

Measuring inflammatory foot disease in rheumatoid arthritis: development and validation of the Rheumatoid Arthritis Foot Disease Activity Index-5

Arthritis Care Res (Hoboken).

Hoque A, Gallagher K, McEntegart A, Porter D, Steultjens M, Woodburn J, Hendry GJ

doi: 10.1002/acr.24259.

Further Publications Rheumatology

Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer

Arthritis Rheumatol

Cunningham-Bussel A, Wang J, Prisco LC, Martin LW, Vanni KMM, Zaccardelli A, Nasrallah M, Gedmintas L, MacFarlane LA, Shadick NA, Awad MM, Rahma O, LeBoeuf NR, Gravallese EM, Sparks JA

doi: 10.1002/art.41949

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes

Arthritis Rheumatol.

Haberman RH, Castillo R, Chen A, Yan D, Ramirez D, Sekar V, Lesser R, Solomon G, Niemann AL, Blank RB, Izmirly P, Webster DE, Ogdie A, Troxel AB, Adhikari S, Scher JU, NYU WARCOV Investigators.

doi: 10.1002/art.41456.

Systemic Sclerosis

Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide

Arthritis Res Ther.

Mitev A, Christ L, Feldmann D, Binder M, Möller K, Kanne AM, Hügle T, Villiger PM, Voll RE, Finzel S, Kollert F

doi: 10.1186/s13075-019-2057-x.

Juvenile Idiopathic Arthritis

Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study

Arthritis Rheumatol.

Ter Haar NM, van Dijkhuizen EHP, Swart JF, van Royen-Kerkhof A, El Idrissi A, Leek AP, de Jager W, de Groot MCH, Haitjema S, Holzinger D, Foell D, van Loosdregt J, Wulffraat NM, de Roock S, Vastert SJ

doi: 10.1002/art.40865.

Rheumatoid ArthritisFurther Publications Rheumatology

MRI detected synovitis of the small joints predicts rheumatoid arthritis development in large joint undifferentiated inflammatory arthritis

Rheumatology (Oxford)

Sidhu N, Wouters F, Niemantsverdriet E, van der Helm-van Mil AHM

doi: 10.1093/rheumatology/keab515

Further Publications Rheumatology

Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment

Semin Arthritis Rheum

Blanken AB, Agca R, van Sijl AM, Voskuyl AE, Boellaard R, Smulders YM, van der Laken CJ, Nurmohamed MT

doi: 10.1016/j.semarthrit.2021.03.008

Related content

Modulation of inflammatory arthritis by gut microbiota through mucosal inflammation and autoantibody generation

Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis

Measuring inflammatory foot disease in rheumatoid arthritis: development and validation of the Rheumatoid Arthritis Foot Disease Activity Index-5

Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer

COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes

Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide

Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study

MRI detected synovitis of the small joints predicts rheumatoid arthritis development in large joint undifferentiated inflammatory arthritis

Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment